MMI
Company

Last deal

$110M

Amount

Series C

Stage

21.02.2024

Date

3

all rounds

$209.8M

Total amount

General

About Company
MMI developed a teleoperated robotic platform for suturing in open surgery with wrinstruments.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Medical Microinstruments, Inc.

founded date

01.01.2015

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

MMI is dedicated to advancing the future of microsurgery by innovating wristed microinstruments and their fabrication process. Their proprietary robotic platform simplifies reconstruction procedures after traumatic injuries and tumor removal in breast, head, and bones. The company believes that the quality of connections made during microsurgical procedures is crucial, and their Symani Surgical System is designed to help surgeons delicately and precisely connect tiny vessels under 2.0mm in diameter. Overall, MMI aims to help surgeons worldwide offer more advanced procedures while reducing costs for patients, hospitals, and society.
Contacts